VC-backed Elevate Credit delays IPO

By Iris Dorbian — 3 weeks ago

Elevate Credit, which is backed by Sequoia Capital and Technology Crossover Ventures, has postponed the pricing of its IPO due to current market volatility. Elevate is a online credit solutions provider.

Continue

VC-backed Clearside Biomedical files for IPO

By Iris Dorbian — 1 month ago

Alpharetta, Georgia-based Clearside Biomedical Inc, which focuses on treating blinding diseases of the eye, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. However, the company plans on trading the stock on the NASDAQ under the ticker symbol “CLSD.” RBC Capital Markets and Stifel will serve as the lead underwriters. Clearside’s backers include Aju IB Investment, Cormorant Asset Management, Perceptive Advisors and Rock Springs Capital Management.

Continue

VC-backed EndoStim pulls IPO

By Iris Dorbian — 2 months ago

According to an SEC filing, St.Louis, Missouri and Netherlands-based EndoStim, which focuses on treating acid reflux, has withdrawn its planned IPO. The reason given was “market conditions.” Its backers include Santé Ventures, Prolog Ventures and Vectis Healthcare & Life Sciences Fund.

Continue

Voyager Therapeutics debuts IPO

By Iris Dorbian — 3 months ago

Cambridge, Massachusetts-based Voyager Therapeutics, a gene therapy company focused on treating central nervous system diseases, has raised $70 million for its IPO after pricing its five million shares at $14 per share. The stock began trading on the NASDAQ under the ticker symbol “VYGR.” Cowen and Company and Piper Jaffray & Co are the lead underwriters. Voyager’s backers included Brookside Capital, Partner Fund Management, Wellington Management Company LLP and Casdin Capital LLC.

Continue

McCarthy & Stone valued at $1.5 bln in London listing: Reuters

By Reuters News — 3 months ago

(Reuters) McCarthy & Stone Plc, Britain’s biggest builder of homes for retired people, said its London debut had been priced at 180 pence per share, valuing the business at 967 million pounds ($1.5 billion). Shares in the company rose 13.5 percent to 204.21 pence in conditional trading on Friday as investors bet on further gains […]

Continue